Abstract
There is increasing concern that contraceptive pill usage may increase the risk of hepatocellular carcinoma. As primary malignant liver cancer is very rare in this country, any effect due to oral contraceptives should be apparent in national mortality statistics. An analysis of mortality rates over the last 24 years shows a small but consistent increase for young women starting to occur during the end of the last decade. However no such trend is apparent in data from other countries where pill usage is comparable to that in the U.K. Overall liver cancer remains an extremely uncommon cause of death in developed countries, but it will be particularly important to monitor trends in this disease in the future.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adlercreutz H., Tenhunen R. Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am J Med. 1970 Nov;49:630–648. doi: 10.1016/s0002-9343(70)80130-9. [DOI] [PubMed] [Google Scholar]
- Baum J. K., Bookstein J. J., Holtz F., Klein E. W. Possible association between benign hepatomas and oral contraceptives. Lancet. 1973 Oct 27;2(7835):926–929. doi: 10.1016/s0140-6736(73)92594-4. [DOI] [PubMed] [Google Scholar]
- Christopherson W. M., Mays E. T., Barrows G. Hepatocellular carcinoma in young women on oral contraceptives. Lancet. 1978 Jul 1;2(8079):38–39. doi: 10.1016/s0140-6736(78)91341-7. [DOI] [PubMed] [Google Scholar]
- Davis M., Portmann B., Searle M., Wright R., Williams R. Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J. 1975 Nov 29;4(5995):496–498. doi: 10.1136/bmj.4.5995.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edmondson H. A., Henderson B., Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976 Feb 26;294(9):470–472. doi: 10.1056/NEJM197602262940904. [DOI] [PubMed] [Google Scholar]
- Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology. 1977 Aug;73(2):386–394. [PubMed] [Google Scholar]
- Mettlin C., Natarajan N. Studies on the role of oral contraceptive use in the etiology of benign and malignant liver tumors. J Surg Oncol. 1981;18(1):73–85. doi: 10.1002/jso.2930180112. [DOI] [PubMed] [Google Scholar]
- Neuberger J., Portmann B., Nunnerley H. B., Laws J. W., Davis M., Williams R. Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis. Lancet. 1980 Feb 9;1(8163):273–276. doi: 10.1016/s0140-6736(80)90776-x. [DOI] [PubMed] [Google Scholar]
- Rooks J. B., Ory H. W., Ishak K. G., Strauss L. T., Greenspan J. R., Hill A. P., Tyler C. W., Jr Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 1979 Aug 17;242(7):644–648. [PubMed] [Google Scholar]
- Shar S. R., Kew M. C. Oral contraceptives and hepatocellular carcinoma. Cancer. 1982 Jan 15;49(2):407–410. doi: 10.1002/1097-0142(19820115)49:2<407::aid-cncr2820490233>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- Vana J., Murphy G. P., Aronoff B. L., Baker H. W. Primary liver tumors and oral contraceptives. Results of a survey. JAMA. 1977 Nov 14;238(20):2154–2158. [PubMed] [Google Scholar]
- Wanless I. R., Medline A. Role of estrogens as promoters of hepatic neoplasia. Lab Invest. 1982 Mar;46(3):313–320. [PubMed] [Google Scholar]
- Wiseman R. A., MacRae K. D. Oral contraceptives and the decline in mortality from circulatory disease. Fertil Steril. 1981 Mar;35(3):277–283. doi: 10.1016/s0015-0282(16)45371-9. [DOI] [PubMed] [Google Scholar]
- Yager J. D., Jr, Yager R. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res. 1980 Oct;40(10):3680–3685. [PubMed] [Google Scholar]